INFI - Infinity Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue6,00018,723109,066
Cost of Revenue---
Gross Profit6,00018,723109,066
Operating Expenses
Research Development20,830119,611199,109
Selling General and Administrative21,615-69,99737,065
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-36,445-30,891-127,108
Income from Continuing Operations
Total Other Income/Expenses Net-5,0952,015435
Earnings Before Interest and Taxes-41,540-28,876-126,673
Interest Expense1,0101,2251,368
Income Before Tax-42,550-30,101-128,041
Income Tax Expense-720-335
Minority Interest---
Net Income From Continuing Ops-41,830-30,101-128,376
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-41,830-30,101-128,376
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-41,830-30,101-128,376